Danimer Scientific Stock Performance
| DNMR Stock | USD 4.74 0.46 8.85% |
The firm shows a Beta (market volatility) of 1.76, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Danimer Scientific will likely underperform. At this point, Danimer Scientific has a negative expected return of -1.36%. Please make sure to confirm Danimer Scientific's potential upside, as well as the relationship between the rate of daily change and relative strength index , to decide if Danimer Scientific performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Danimer Scientific has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's primary indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors. ...more
Actual Historical Performance (%)
One Day Return (13.75) | Five Day Return (28.01) | Year To Date Return (89.22) | Ten Year Return (98.84) | All Time Return (98.84) |
Last Split Factor 1:40 | Last Split Date 2024-11-13 |
1 | Eagle Beverage Opens State of the Art PHA Injection Molding Manufacturing Facility | 09/10/2024 |
2 | Danimer Scientific Inc Q2 2024 Earnings Call Highlights Navigating Revenue Decline and ... | 10/09/2024 |
3 | Acquisition by Richard Hendrix of 250000 shares of Danimer Scientific at 0.55 subject to Rule 16b-3 | 10/14/2024 |
4 | Danimer Scientific appoints Richard Altice as interim CEO | 10/15/2024 |
5 | Acquisition by Richard Hendrix of 50725 shares of Danimer Scientific subject to Rule 16b-3 | 10/18/2024 |
6 | MSC Industrial Q4 Earnings and Revenues Lag Estimates | 10/24/2024 |
7 | LegalZoom Surpasses Q3 Earnings and Revenue Estimates | 11/06/2024 |
8 | Armistice Capital, LLC Increases Stake in Danimer Scientific Inc | 11/15/2024 |
9 | Danimer Scientific Announces Third Quarter 2024 Results | 11/19/2024 |
10 | TerraNova Capital Equities announces three transactions totaling 45 Million | 11/20/2024 |
11 | Acquisition by Stephen Croskrey of 678295 shares of Danimer Scientific subject to Rule 16b-3 | 11/22/2024 |
| Begin Period Cash Flow | 64.4 M |
Danimer |
Danimer Scientific Relative Risk vs. Return Landscape
If you would invest 1,368 in Danimer Scientific on August 28, 2024 and sell it today you would lose (894.00) from holding Danimer Scientific or give up 65.35% of portfolio value over 90 days. Danimer Scientific is currently does not generate positive expected returns and assumes 7.8699% risk (volatility on return distribution) over the 90 days horizon. In different words, 70% of stocks are less volatile than Danimer, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Danimer Scientific Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Danimer Scientific's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Danimer Scientific, and traders can use it to determine the average amount a Danimer Scientific's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1725
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | DNMR |
Estimated Market Risk
| 7.87 actual daily | 70 70% of assets are less volatile |
Expected Return
| -1.36 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.17 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Danimer Scientific is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Danimer Scientific by adding Danimer Scientific to a well-diversified portfolio.
Danimer Scientific Fundamentals Growth
Danimer Stock prices reflect investors' perceptions of the future prospects and financial health of Danimer Scientific, and Danimer Scientific fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Danimer Stock performance.
| Return On Equity | -0.46 | ||||
| Return On Asset | -0.088 | ||||
| Operating Margin | (2.46) % | ||||
| Current Valuation | 406.55 M | ||||
| Shares Outstanding | 3.02 M | ||||
| Price To Earning | 12.41 X | ||||
| Price To Book | 0.07 X | ||||
| Price To Sales | 0.40 X | ||||
| Revenue | 46.68 M | ||||
| Gross Profit | 2.8 M | ||||
| EBITDA | (96.45 M) | ||||
| Net Income | (155.47 M) | ||||
| Cash And Equivalents | 140.39 M | ||||
| Cash Per Share | 1.39 X | ||||
| Total Debt | 408.07 M | ||||
| Debt To Equity | 0.61 % | ||||
| Current Ratio | 6.60 X | ||||
| Book Value Per Share | 108.14 X | ||||
| Cash Flow From Operations | (47.26 M) | ||||
| Earnings Per Share | (40.40) X | ||||
| Market Capitalization | 15.7 M | ||||
| Total Asset | 698.13 M | ||||
| Retained Earnings | (454.12 M) | ||||
| Working Capital | 92.31 M | ||||
About Danimer Scientific Performance
Assessing Danimer Scientific's fundamental ratios provides investors with valuable insights into Danimer Scientific's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Danimer Scientific is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 125.25 | 107.29 | |
| Return On Tangible Assets | (0.25) | (0.26) | |
| Return On Capital Employed | (0.18) | (0.19) | |
| Return On Assets | (0.22) | (0.23) | |
| Return On Equity | (0.56) | (0.59) |
Things to note about Danimer Scientific performance evaluation
Checking the ongoing alerts about Danimer Scientific for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Danimer Scientific help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Danimer Scientific generated a negative expected return over the last 90 days | |
| Danimer Scientific has high historical volatility and very poor performance | |
| Danimer Scientific has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 46.68 M. Net Loss for the year was (155.47 M) with profit before overhead, payroll, taxes, and interest of 2.8 M. | |
| Danimer Scientific currently holds about 140.39 M in cash with (47.26 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.39. | |
| Danimer Scientific has a poor financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: TerraNova Capital Equities announces three transactions totaling 45 Million |
- Analyzing Danimer Scientific's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Danimer Scientific's stock is overvalued or undervalued compared to its peers.
- Examining Danimer Scientific's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Danimer Scientific's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Danimer Scientific's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Danimer Scientific's stock. These opinions can provide insight into Danimer Scientific's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Danimer Stock Analysis
When running Danimer Scientific's price analysis, check to measure Danimer Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Danimer Scientific is operating at the current time. Most of Danimer Scientific's value examination focuses on studying past and present price action to predict the probability of Danimer Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Danimer Scientific's price. Additionally, you may evaluate how the addition of Danimer Scientific to your portfolios can decrease your overall portfolio volatility.